Early assessment of a new anticancer drug analogue — are the historical comparisons obsolete? The French experience with pirarubicin
Authors:
- N. PoutignatNPN. Poutignat
- M. MartyMMM. Marty
- R. BugatRBR. Bugat
- 1 January 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 28 (10) , 1670-1676
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Phase II Trial of Mitoxantrone in Advanced Gastric CancerOncology, 1988
- Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1987
- Patient treatment preference in advanced breast cancer: A randomized cross-over study of doxorubicin and mitozantroneEuropean Journal of Cancer and Clinical Oncology, 1987
- Phase II Trial of 4′-Epidoxorubicin in Advanced Gastrointestinal TumorOncology, 1986
- Mitoxantrone in advanced bladder carcinoma. A phase II study of the EORTC genito-urinary tract cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1985
- An EORTC phase II study of mitoxantrone in solid tumors and lymphomasEuropean Journal of Cancer and Clinical Oncology, 1984
- Mitoxantrone for the treatment of advanced breast cancer: Single-agent therapy in previously untreated patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1984
- Estimation of confidence limits for the cumulative probability of survival in life table analysisJournal of Chronic Diseases, 1978